Your browser doesn't support javascript.
loading
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco, Alvino; Matrone, Federica; Capobianco, Marco; De Luca, Giovanna; Filippi, Massimo; Granella, Franco; Lus, Giacomo; Marfia, Girolama Alessandra; Mirabella, Massimiliano; Patti, Francesco; Trojano, Maria; Mascolo, Agnese; Copetti, Massimiliano; Tedeschi, Gioacchino; Gallo, Antonio.
Afiliação
  • Bisecco A; I Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy. alvino.bisecco@unicampania.it.
  • Matrone F; I Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
  • Capobianco M; SCDO Neurology and Regional Reference Multiple Sclerosis Center, A.O.U. San Luigi, Orbassano, Italy.
  • De Luca G; Department of Neurology, AO S. Croce e Carle, Cuneo, Italy.
  • Filippi M; Multiple Sclerosis Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.
  • Granella F; MS Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lus G; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Marfia GA; Vita-Salute San Raffaele University, Milan, Italy.
  • Mirabella M; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Patti F; Multiple Sclerosis Centre, Unit of Neurology, Department of General Medicine, Parma University Hospital, Parma, Italy.
  • Trojano M; MS Center - II Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Mascolo A; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.
  • Copetti M; Multiple Sclerosis Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
  • Tedeschi G; Centro Di Ricerca Sclerosi Multipla (CERSM), Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gallo A; Department of Medical and Surgical Sciences and Advanced Technologies, G. F. Ingrassia, University of Catania, Catania, Italy.
J Neurol ; 271(2): 699-710, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37982852
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article